GEXVal Featured by Australian Media Outlets

GEXVal Inc.
October 13, 2022

GEXVal has announced that it has met Nick Champion, a member of the South Australian parliament (Minister of Trade and Investment, Minister of Housing and Urban Development, and Minister of Planning), reported on the start of Phase 1 clinical trials of GXV-001, and exchanged opinions on strengthening collaboration in the future. An outline of the meeting was featured on the official website of South Australian government and on the Twitter account of Nick Champion, who is a minister in the South Australian government.

Links to each article:
Website of the South Australian Government
https://dti.sa.gov.au/articles/south-australia-lures-leading-biotech-company-gexval-clinical-trials

https://www.linkedin.com/posts/depttradeinvestment_south-australia-lures-leading-biotech-company-activity-6986165655154688000-D9c8?utm_source=share&utm_medium=member_desktop

Nick Champion’s Twitter
https://twitter.com/NickChampionMP/status/1580298467850612737

Indaily
https://indaily.com.au/news/2022/10/13/japanese-biotech-company-to-undertake-clinical-trials-in-sa/

GEXVal strives to generate extra value to deliver cost-effective, innovative treatment options to improve health and QoL of patients and families affected by rare and intractable diseases.

Please note that GEXVal has not disclosed the size of the development program and does not provide any basis for the size of investment.

For further information, please contact us: info@gexval.com